Last reviewed · How we verify
Intravenous stem cell transplantation — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intravenous stem cell transplantation (Intravenous stem cell transplantation) — Southern Medical University, China.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravenous stem cell transplantation TARGET | Intravenous stem cell transplantation | Southern Medical University, China | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravenous stem cell transplantation CI watch — RSS
- Intravenous stem cell transplantation CI watch — Atom
- Intravenous stem cell transplantation CI watch — JSON
- Intravenous stem cell transplantation alone — RSS
Cite this brief
Drug Landscape (2026). Intravenous stem cell transplantation — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-stem-cell-transplantation. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab